The Homeopathy Journal
Current, sourced and readable: Indian culture, viral controversies, dilution science, global policy and the questions people are already asking.
Homeopathy persists in India because it is more than a bottle of pills. It sits inside family memory, neighbourhood access, ideas of gentle care and dissatisfaction with rushed healthcare—while its clinical evidence remains heavily contested.
Read the storyFresh thinking
21 sourced articles
The controversy was not only about one celebrity. It became a proxy battle over lived experience, scientific standards, professional identity and whether personal testimony should influence public health choices.
Read the storyA 30C preparation conventionally involves thirty 1-in-100 dilution steps, with shaking at each stage. The resulting nominal dilution is 1 in 10^60, which is why 30C sits at the centre of scientific arguments about homeopathy.
Read the storyThe WHO strategy does not declare every traditional or complementary therapy effective. It calls for stronger evidence, safety systems, regulation and informed integration—and those qualifiers are the story.
Read the storyGermany changed what statutory health insurance can reimburse for certain homeopathic and anthroposophic medicines. The decision concerns public payment rules; it is not a universal ban on possession or private purchase.
Read the storyThe Maharashtra dispute concerns whether and how certain BHMS graduates with an additional pharmacology course may receive modern-medicine registration. Court orders, government directions and professional objections made the position fast-moving.
Read the storyStart with the study question, not the conclusion. Then inspect the comparison group, preregistered outcomes, sample size, missing data and whether independent teams reproduced the finding.
Read the storyA retraction tells readers that a journal no longer considers a paper reliable enough to remain part of the scientific record. The notice and reason matter; neither defenders nor critics should claim more than it establishes.
Read the storyHomeopathy debates go viral because they are identity conflicts disguised as fact checks. One side hears an attack on family experience; the other hears a threat to evidence and patient safety. Algorithms reward the collision.
Read the storyWhen people ask whether improvement was ‘just placebo,’ they are usually asking whether their experience was real. The experience can be real while the cause remains uncertain; separating context from specific treatment effects is the scientific task.
Read the storyThere is no single international homeopathy rulebook. Countries differ on practitioner titles, product registration, advertising, reimbursement, prescribing and cross-border telemedicine.
Read the storyHomeopathy became Indian through translation, influential early patients, Bengali intellectual networks, charitable dispensaries, colleges and eventually statutory recognition. India did not merely import the system; it built institutions around it.
Read the storyThe National Commission for Homoeopathy sets major national rules for education, professional conduct, recognised qualifications and registers. State authorities and councils also matter for individual registration and practice.
Read the storyIndia’s BHMS programme combines homoeopathic subjects with anatomy, physiology, pathology, surgery, medicine, community medicine, research methods and clinical training. It is a distinct qualification, not an MBBS equivalent.
Read the storyThe law of similars proposes that a substance associated with certain symptoms in a healthy person may be selected for a patient with a similar symptom pattern. It is a homeopathic principle, not a general law established by modern biology.
Read the storySuccussion means forcefully shaking a preparation at each stage of serial dilution. Homeopathic theory treats this process as important to potency; conventional science has not established that it creates disease-specific effects at extreme dilutions.
Read the storyIndividualisation complicates research because the prescription varies by patient, but it does not make controlled testing impossible. Trials can randomise access to the complete consultation-and-prescribing strategy or standardise the decision process.
Read the storyThe WHO global report draws on responses from 106 Member States and tracks how traditional, complementary and integrative medicine enters policy, education, products and health services. It measures systems, not blanket clinical endorsement.
Read the storyInsurance coverage shows that a payer funds a service under particular rules. It can reflect evidence, law, contracts, politics, demand and budgets; coverage alone neither proves nor disproves clinical effectiveness.
Read the storyPause before asking whether the remedy sounds natural. First identify the exact promise, whether the condition needs diagnosis, who made the claim, what evidence is linked and what harm could follow from delay.
Read the storyA case report can document an unusual clinical story and generate a research question. A controlled trial estimates comparative outcomes across groups. Neither design answers every question, but they carry very different causal weight.
Read the storyOur editorial promise
Every article leads with a direct answer, links its sources and distinguishes popularity from proof. Medical decision pages remain outside search until named clinical review is recorded.
Follow on Google
Get our articles surfaced with a “preferred” badge in Google Search, Top Stories, and AI Mode.
Can’t see the button? Add us directly.
